Immunovant Inc

IMVT NASDAQ Santé & Biotech États-Unis US45258J1025
31.41 $
0.50 %

Immunovant Inc se spécialise dans le développement de traitements immuno-modulateurs pour combattre les maladies auto-immunes.

Performance & Momentum

6 Months 37.08 %
1 Year 104.73 %
3 Years 49.69 %
5 Years 216.26 %

Similar stocks to Immunovant Inc

Anantys Community

Be the first to share your analysis on Immunovant Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases